ALGS Stock Summary and Trading Ideas (Aligos Therapeutics | NASDAQ:ALGS)

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

What symbol and exchange does Aligos Therapeutics shares trade?

Aligos Therapeutics trades on the NASDAQ stock market under the symbol ALGS.

What is Aligos Therapeutics stock price doing today?

As of December 18, 2025, ALGS stock price declined to $10.37 with 51,954 million shares trading.

What is Aligos Therapeutics's Beta?

ALGS has a beta of 2.21, meaning it tends to be more sensitive to market movements. ALGS has a correlation of 0.11 to the broad based SPY ETF.

How much is Aligos Therapeutics worth?

ALGS has a market cap of $63.81 million. This is considered a Micro Cap stock.

How much money does Aligos Therapeutics make?

Last quarter Aligos Therapeutics reported $741,000 in Revenue and -$3.04 earnings per share. This beat revenue expectation by $241,000 and missed earnings estimates by -$1.00.

What is the highest and lowest price Aligos Therapeutics traded in the last 3 year period?

In the last 3 years, ALGS traded as high as $60.25 and as low as $3.76.

What are the top ETFs holding Aligos Therapeutics?

The top ETF exchange traded funds that ALGS belongs to (by Net Assets): VTI, VXF, AVSC, DCOR.

Is Aligos Therapeutics (ALGS) a good investment?

ALGS has underperformed the market in the last year with a return of -69.9%, while SPY returned +13.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ALGS shares. However, ALGS has outperformed the market in the last 3 month and 2 week periods, returning +12.5% and +5.1%, while SPY returned +2.9% and -1.1%, respectively. This indicates ALGS has been having a stronger performance recently.

What are the support and resistance levels for Aligos Therapeutics (ALGS)?

ALGS support price is $9.94 and resistance is $11.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALGS shares will trade within this expected range on the day.